Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CKAP2 divergent transcript (CKAP2-DT) is a long non-coding RNA (lncRNA) gene located near the CKAP2 locus on human chromosome 13. Divergent transcripts are a class of lncRNAs transcribed in the opposite direction from nearby protein-coding genes within a short genomic distance (typically within 300-500 base pairs). The specific biological role and disease association of CKAP2-DT have not been thoroughly characterized in publicly available literature; it is primarily annotated as a genomic feature without clear evidence as a therapeutic target or established biomarker. This distinguishes it from the protein-coding gene CKAP2 (cytoskeleton associated protein 2), which is involved in microtubule stabilization, cell division, and has been studied as a biomarker and mechanistic contributor to several diseases, including cancer and rheumatoid arthritis. If you are seeking information on the protein-coding gene CKAP2, it is a distinct entity from CKAP2-DT. CKAP2-DT as a divergent transcript does not code for a protein and does not currently meet criteria for a druggable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CKAP2 divergent transcript (CKAP2-DT).